Last reviewed: June 26, 2026
Last updated: June 26, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that reduces appetite and helps regulate blood sugar, with clinical trials showing average weight loss of 15% over 68 weeks. The medication does not work at a fixed dose for everyone—your starting point and escalation schedule depend on your individual metabolism, health history, and weight loss goals. PlexusDx delivers compounded semaglutide injections from licensed 503A pharmacies with personalized dosing guidance tailored to your needs.
How Semaglutide Dosing Works for Weight Loss
Semaglutide treatment follows a titration schedule, meaning your dose increases gradually over several weeks rather than jumping to a full therapeutic amount immediately. Most patients begin at 0.25 mg once weekly, then progress through 0.5 mg, 1.0 mg, 1.7 mg, and finally 2.4 mg depending on how well they tolerate the medication and respond to treatment. This slow escalation allows your digestive system and appetite-control centers in your brain to adapt, reducing nausea and other adjustment-related side effects.
The goal of titration is to find your effective dose—the amount that produces meaningful weight loss while remaining tolerable for your lifestyle. Some patients feel satisfied at 1.0 mg weekly, while others benefit from reaching the full 2.4 mg dose used in major clinical trials. Your healthcare provider monitors your progress every 2–4 weeks and may adjust the pace of dose increases based on your reported appetite suppression, weight trends, and any side effects you experience.
Semaglutide Dose Escalation Timeline and What to Expect
A standard semaglutide dose escalation typically spans 16–20 weeks, moving up by 0.25 mg increments every 7 days at the beginning, then by 0.25 mg every 2–4 weeks as you reach higher doses. Week 1 through 4 usually covers the 0.25 mg and 0.5 mg range, where many patients notice their first appetite reduction and may feel mild nausea or mild gastrointestinal changes. Weeks 5 through 12 continue the climb toward 1.0 mg to 1.7 mg, a phase where most people report sustained appetite control and consistent weekly weight loss of 0.5–1.0 pound.
The final phase pushes toward your target maintenance dose, typically 1.7 mg or 2.4 mg weekly, which takes another 4–8 weeks to reach comfortably. During this entire process, your dose may need to go up—your price won't. PlexusDx charges a flat monthly rate whether you remain at 0.5 mg or advance to 2.4 mg, eliminating the financial barrier to finding your optimal therapeutic dose.
Factors That Influence Your Semaglutide Dose Level
Your starting dose and titration speed depend on your baseline health metrics, kidney function, stomach sensitivity, and prior medication responses. Patients with a history of gastrointestinal issues may begin at a lower starting dose or progress more slowly to allow gut adaptation; conversely, those with robust baseline digestion may tolerate faster escalation. Your weight, metabolic rate, and insulin sensitivity also matter—the Precision Peptide Genetic Test offered by PlexusDx analyzes variants in your GLP1R (rs6923761) and GIPR (rs1800437) genes to reveal how efficiently your body responds to GLP-1 signaling.
Age, concurrent medications, and your target weight loss goal shape the final dose recommendation as well. Older adults or those taking medications that slow stomach emptying may reach their therapeutic effect at a lower maintenance dose, while younger, insulin-resistant patients often benefit from the full 2.4 mg weekly. Your PlexusDx clinician integrates these factors into a personalized protocol that balances efficacy with your comfort and lifestyle.
Maintaining Your Semaglutide Dose Long-Term
Once you reach your target maintenance dose—whether that is 1.0 mg, 1.7 mg, or 2.4 mg weekly—you typically continue that same amount each week for as long as you are using semaglutide. Long-term studies suggest that sustained weight loss requires ongoing therapy; stopping the medication often leads to gradual weight regain over several months. Most patients stay on their established dose for 12–24 months or longer, with periodic check-ins to confirm continued weight loss, stable side effects, and overall health benefits.
Occasionally, your dose may need adjustment downward if you experience persistent nausea, vomiting, or other tolerability issues, or upward if weight loss plateaus and your clinician determines a higher dose is appropriate and safe for you. PlexusDx supports dose adjustments at any time without penalty—your monthly price remains flat regardless of whether you taper, hold steady, or advance your semaglutide injection dose.
Comparing Semaglutide Injection to Oral Semaglutide Dosing
Semaglutide comes in two formulations: injectable (once weekly) and oral (once daily), each with its own dosing structure. Oral semaglutide begins at 3 mg daily, increases by 3 mg weekly until reaching 7 mg daily, then steps up to 14 mg daily for maintenance—a longer titration requiring daily pill adherence and must be taken on an empty stomach. Injection semaglutide follows the simpler weekly schedule outlined above, with better absorption predictability and once-per-week dosing convenience.
For weight loss specifically, injectable semaglutide at 2.4 mg weekly produces slightly greater average weight loss (around 15% body weight) compared to oral semaglutide at 14 mg daily (around 10% body weight) in head-to-head trials. PlexusDx offers compounded semaglutide injections starting at $149/month and oral semaglutide starting at $249/month, allowing you to choose the format that fits your preference and lifestyle while maintaining a predictable, flat monthly cost.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the starting dose of semaglutide for weight loss?
The standard starting dose is 0.25 mg injected once weekly. This low initial dose allows your body to adjust and minimizes nausea while your clinician monitors your early response. PlexusDx delivers your starting dose via compounded semaglutide injections from licensed 503A pharmacies at a flat $149/month rate, regardless of which dose in the escalation you are currently using.
How long does it take to reach the full semaglutide dose?
Most patients reach their target maintenance dose within 16–20 weeks, progressing by 0.25 mg increments every 1–4 weeks depending on tolerability and response. Some individuals feel satisfied at 1.0 mg or 1.7 mg, while others advance to the full 2.4 mg weekly dose. Your PlexusDx provider adjusts your escalation pace based on your weight loss progress and any side effects you report.
Does my monthly price increase if I move up to a higher dose?
No. PlexusDx charges a flat monthly rate for semaglutide injections starting at $149/month, and that price holds whether you remain at 0.25 mg or reach 2.4 mg—your dose may need to go up, your price won't. This flat-rate model removes the financial barrier to finding your optimal dose.
What happens if I experience side effects from semaglutide?
Mild nausea, vomiting, and constipation are common during dose escalation and often resolve within 1–2 weeks as your body adapts. If side effects persist or worsen, your PlexusDx clinician may slow your dose increase, temporarily hold at your current dose, or reduce it slightly. Rare but serious side effects (pancreatitis, severe dehydration) require immediate medical attention and discussion with your provider.
How does the Precision Peptide Genetic Test help with my semaglutide dosing?
PlexusDx's Precision Peptide Genetic Test analyzes 14 metabolic pathways and 49 peptides, including your GLP1R and GIPR genetic variants, to reveal how efficiently your cells respond to semaglutide signaling. Patients with certain genetic profiles may achieve meaningful weight loss at lower doses, while others benefit from advancing to higher doses. This $99 add-on test (available after your first month of treatment) personalizes your entire dosing strategy.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
When Does Mounjaro Start Working After Injection?
Navigating Ozempic Use with Diabetic Retinopathy: What You Need to Know